Loading…
Loading…
VIRS (Pacer BioThreat Strategy ETF) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
See exactly how VIRS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for VIRS and 80,000+ other tickers.
This exchange-traded fund focuses its investments on U.S.-listed companies that offer products or services aimed at protecting against, enduring, or recovering from biological threats to human health. Its portfolio manager strives to allocate nearly all of the fund's capital to the specific securities that comprise its benchmark index. Notably, this fund operates on a non-diversified basis.
As we face the last quarter of 2024, interest rates are finally heading down, kicked off by a 50 basis point Fed cut, the election race is too close to call, and global geopolitical instability remains a risk factor.
MALVERN, Pa.--(BUSINESS WIRE)--Pacer Advisors, Inc. to Close and Liquidate the Pacer BioThreat Strategy ETF (VIRS) and the Pacer CSOP FTSE China A50 ETF (AFTY).
Netflix (NFLX) topped both earnings and revenue estimates and delivered its strongest first-quarter customer additions since the pandemic. However, it issued disappointing second-quarter revenue guidance, which dragged the stock down.
Netflix has risen about 26% over the past three months and has a reasonable chance to beat earnings estimates.
A highly-mutated Covid-19 variant designated as BA.2.86, referred to as "Pirola," has surfaced and been detected in many countries.